Consider the example from the US of GlaxoSmithKline’s Advair (seretide) formulation, which came off patent in 2010 [although integration as part of the Diskus delivery device extended the patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback